DEFINITIVE PROXY STATEMENT

Company

ORAMED PHARMACEUTICALS INC.

Filed

June 2, 2022

Period of Report

June 30, 2022

Accession Number

0001213900-22-030956

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →